We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Erba Mannheim Makes SARS-CoV-2 Testing Available to Labs Everywhere

By HospiMedica International staff writers
Posted on 03 Jul 2020
Print article
Image: ErbaLisa COVID-19 IgM ELISA kit (Photo courtesy of Erba Mannheim)
Image: ErbaLisa COVID-19 IgM ELISA kit (Photo courtesy of Erba Mannheim)
Erba Mannheim (London, England) has taken up the challenge of providing labs and clinicians everywhere with reliable and affordable solutions to SARS-CoV-2 testing.

The company’s efforts come amidst the serious challenges in the supply of material related to sampling and testing of SARS-CoV-2, as well as public confusion over the utility of some types of test. With two main technologies emerging for SARS-CoV-2 testing: molecular (primarily PCR) and serology (ELISA, rapid tests, IFA), Erba has joined the fight against COVID-19 by launching the ErbaLisa IgG and IgM antibody ELISA kits. These tests have been developed and manufactured entirely in California, US by Calbiotech, the immunoassay center of excellence of the Erba Mannheim group.

Similar to its ErbaLisa ELISA range, Erba has continued to maintain quality and performance as the top priorities for its COVID-19 antibody assays. The IgG kits use Spike protein antigens to ensure clinical relevance and specificity, and the IgM kits employ a combination of Spike and Nucleocapsid antigens. Additionally, Erba has extensively validated the performance and accuracy of these tests through multiple studies in partnership with public and private laboratories, as well as universities. Aside from being CE marked, and pending EUA authorization in the US, the ErbaLisa COVID-19 tests have also been approved by strict regulatory bodies across the globe, from ANVISA in Brazil to the ICMR in India.

In addition to ensuring quality and performance of its ErbaLisa COVID-19 tests, Erba is now focusing on making these tests available to labs everywhere. The company remains committed to making quality diagnostic solutions affordable to growing labs across all the emerging markets in Asia, Latin America, the Middle East and Africa. Amidst the ongoing challenges in supply of reliable COVID-19 tests and long-standing IVD companies giving higher priority to meeting the demand in Europe and North America, Erba’s commitment to the emerging markets assumes greater significance.


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Illuminator
Trimline Basic

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more